Panel Discussion:

• Can we prevent IUGR?
• Can we prevent GDM?
• Can we prevent T2DM in GDM patients?
• Can we prevent Uterine rupture in TOLAC?
• Can we prevent PPH?
• Can we prevent Shoulder Dystocia?

Priv.-Doz. Dana A. Muin, MD MMSc MRes, is a Consultant subspecialist in feto-maternal and perinatal medicine at the University Clinic of Obstetrics and Gynaecology, Comprehensive Centre for Paediatrics in Vienna, Austria. Following medical graduation from Vienna, she completed a 2-year foundation training within the East of England Deanery and obtained her specialist training in the UK, Switzerland and Austria. Beside her medical degree, Dr Muin received a Master of Science in Gender Medicine, a Master of Science in Medical Genetics and a Master of Research in Pregnancy and Reproduction. Dr Muin’s research focuses on intrauterine fetal death and placental dysfunction leading to intrauterine growth restriction and eventually stillbirth. In 2018, she worked one year at the Tommy’s Stillbirth Research Centre in Manchester, UK. Currently, she is the head of the Stillbirth Research Group “Austrian Stillbirth Alliance” at the Medical University of Vienna, collaborating with national and international researchers on epidemiological data and conducting laboratory investigations in the field of placental dysfunction. Her goal is to contribute to early detection of fetal compromise and establish prevention strategies to help reduce antepartum stillbirth worldwide.